Shimadzu Microow Liquid Chromatography Mass Spectrometry System Nexera Mikros

Importance of the Topic

Overcoming the sensitivity limitations of conventional semimicro-flow LC/MS is essential for accurate quantitation of trace-level analytes in biological and industrial samples. Microflow liquid chromatography coupled with mass spectrometry (LC/MS) offers enhanced signal-to-noise ratios, reduced solvent consumption, and improved matrix tolerance, meeting the growing demands in bioanalysis, pharmaceutical monitoring, and proteomics.

Objectives and Study Overview

This white paper presents the design, performance, and applications of the Shimadzu Nexera Mikros microflow LC/MS system. The goals are to demonstrate:

• Enhanced detection limits for small molecules and peptides compared with semimicro-flow methods.
• Robustness and stability over extended sequences of complex-sample injections.
• Ease of use through innovative source and column interfacing technologies.

Methodology

Microflow LC/MS experiments were conducted using flow rates between 1 and 10 µL/min with 0.1–1.0 mm I.D. columns at controlled temperatures. Gradient elution and multiple reaction monitoring (MRM) or high-resolution detection were employed for quantitation. Sample types included vitamin D metabolites, antiarrhythmic drugs in plasma, and peptides derived from monoclonal antibodies.

Instrumentation

• Nexera Mikros microflow LC system with direct-drive LC-Mikros pump (1–500 µL/min, 80 MPa)
• Micro-ESI 8060/9030 sources with X–Y adjustable spray stage
• CTO-Mikros column oven with UF-Link zero-dead-volume connector
• SIL-40C XR autosampler with programmable loop cut-off
• LCMS-8060NX triple quadrupole MS with UF-Qarray II ion guide and UF-Lens II
• Shim-pack columns: MC C18 (1.9 µm), MC PLONAS series (2.7 µm superficially porous), and trap columns (Shim-pack MCT C18/C8)

Main Results and Discussion

• Vitamin D metabolites: microflow LC/MS achieved 3–5× improvement in signal-to-noise ratios over semimicro-flow methods for low-abundance dihydroxy metabolites.
• Antiarrhythmic agents: fivefold and fourfold S/N gains were observed for verapamil and norverapamil, respectively, in plasma matrices.
• Monoclonal antibody bioanalysis: nSMOL workflow coupled with Nexera Mikros delivered 12× higher signal for Fab-derived peptides, an LLOQ of 0.025 µg/mL, linear range of 0.00763–62.5 µg/mL (R2>0.99), and accuracy within ±10%.
• System ruggedness: 1,500 consecutive plasma injections with QC checks showed 4.38% RSD in peak area and 0.25% RSD in retention time, with no loss of peak shape.

Benefits and Practical Applications

By combining microflow sensitivity with HPLC robustness, Nexera Mikros enables:

• Trace-level quantitation in bioanalysis, pharmacokinetics, and therapeutic drug monitoring.
• High-throughput workflows with minimized solvent use and reduced carryover.
• Reliable operation in regulated laboratories due to stable retention times and low maintenance downtime.

Future Trends and Applications

Continued development in microflow LC/MS is expected to focus on:

• Integration of trap-and-elute and make-up-flow configurations for broader sample compatibility.
• Advanced column chemistries and superficially porous particles for challenging separations.
• Automation and AI-driven method optimization to further enhance throughput and data quality.
• Expansion into multi-omics, environmental monitoring, and continuous process analysis.

Conclusion

The Shimadzu Nexera Mikros microflow LC/MS system delivers significant gains in sensitivity, stability, and ease of use for trace-level analyses. Its innovative pump, source, and column interfacing technologies ensure robust, high-throughput performance across small-molecule and peptide applications, addressing critical needs in bioanalysis and industrial quality control.

References

None